External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice
Sign Up to like & getrecommendations! Published in 2017 at "Immunopharmacology and Immunotoxicology"
DOI: 10.1080/08923973.2017.1312436
Abstract: Abstract Context: Dehydroxymethylepoxyquinomicin (DHMEQ) which is originally developed as an analog of antibiotic epoxyquinomicin C is a specific and potent inhibitor of NF-κB and has been shown to possess promising potential as an anti-inflammatory and… read more here.
Keywords: dermatitis like; induced dncb; like lesions; lesions induced ... See more keywords